p53 Modulates Radiosensitivity in Head and Neck Cancers—From Classic to Future Horizons
p53, initially considered a tumor suppressor, has been the subject of research related to cancer treatment resistance in the last 30 years. The unfavorable response to multimodal therapy and the higher recurrence rate, despite an aggressive approach, make HNSCC a research topic of interest for impro...
| Hlavní autoři: | , , |
|---|---|
| Médium: | Článek |
| Jazyk: | English |
| Vydáno: |
MDPI AG
2022-12-01
|
| Edice: | Diagnostics |
| Témata: | |
| On-line přístup: | https://www.mdpi.com/2075-4418/12/12/3052 |